Non-Invasive Cooling of Fat Cells

Zeltiq Aesthetics

Status

Completed

Conditions

Reduction of Unwanted Fat

Treatments

Device: Zeltiq Dermal Cooling Device

Study type

Interventional

Funder types

Industry

Identifiers

NCT00762437

ZA07005

Details and patient eligibility

About

The purpose of this study is to evaluate a non-invasive cooling device to determine if cold exposure will consistently result in a reduction of subcutaneous fat.

Enrollment

175 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Male or female subjects > 18 years of age.
Subject has clearly visible fat on an area of the body appropriate for treatment with the non-invasive Zeltiq cooling device such as the flanks, thighs, abdomen or back.
Subject has not had weight change fluctuations exceeding 10 pounds in the preceding month and plans to maintain their weight to within ±10 pounds over the next 6 months.
Subject has read and signed a written informed consent form.

Exclusion criteria

Subject has had liposuction, or another surgical procedure(s) or mesotherapy in area of intended treatment within the past 2 years.
Subject has a known history of subcutaneous injections into the area of intended treatment (e.g., cortisone) within the past 6 months.
Subject has a known history of cryoglobulinemia, cold urticaria, or paroxysmal cold hemoglobinuria.
Subject has used diet pills within the past 6 months.
Subject is unable or unwilling to comply with the study requirements.
Subject has any dermatological conditions or scars within the location of the test sites that may interfere with the treatment or evaluation.
Subject is currently enrolled in a clinical study of any other unapproved investigational drug or device.
Patient is pregnant or intending to become pregnant in the next 9 months.
Patient is lactating or has been lactating in the past 9 months.
Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect response or participation in this clinical study, or would pose an unacceptable risk to the subject.